| Document |
Document Title |
|
WO/2008/060130A2 |
The invention relates to detergent compositions in the form of stable, transparent oil-in-water-type microemulsions which are prepared in accordance with the invention and which take the form of a liquid or gel. The aforementioned compos...
|
|
WO/2008/046676A1 |
Cosmetic composition, in particular styling composition, comprising, in a cosmetically acceptable carrier, in each case based on the total composition, a) 0.0001 to 5% by weight of purine and/or purine derivative(s) and b) 0.0001 to 5% b...
|
|
WO/2008/047709A1 |
Disclosed is an NK1 receptor antagonist composition comprising a maltooligosaccharide having an antagonistic activity on an NK1 receptor as an active ingredient. Preferably, the maltooligosaccharide is contained in the NK1 receptor antag...
|
|
WO/2008/047680A1 |
Disclosed is an external preparation for the skin, which comprises a phospholipid having an iodine value of 80 to 110, ethanol in an amount of 55 to 83 wt% and water in an amount of 15 to 43 wt%, and which is improved in preparation stab...
|
|
WO/2008/043644A2 |
The invention relates to the use of an agent containing active ingredients obtained from plants of the genus dandelion (Leontodon or Taraxacum) for treating hair, in particular for revitalising hair, stimulating the energy metabolism in ...
|
|
WO/2008/041608A1 |
It is intended to provide a skin external preparation which can exert an excellent effect of improving skin symptoms because of containing molybdenum and a hair-care product which can exert an excellent hair-growing or hair-nourishing ef...
|
|
WO/2008/036054A2 |
The present invention provides a composition to treat androgenetic alopecia in men and female pattern hair loss in women, thinning disorders, alopecia areata, alopecia totalis and promotes hair growth even in peeled regions. The present ...
|
|
WO/2008/031685A1 |
The invention relates to the use of a means, containing active ingredients obtained from plants of the species Harpagophytum, for treating hair, in particular, for vitalising hair, reactivating hair roots, activating hair follicles, prom...
|
|
WO/2008/031684A1 |
The invention relates to the use of a means, containing active ingredients, which may be obtained from plants of the species Apium, for treating hair, in particular, for vitalising hair, stimulating metabolism in hair follicles, activati...
|
|
WO/2008/028776A1 |
The invention relates to cosmetic agents, in particular hair treatment agents, containing at least one specific emulsifier and at least one bioquinone. Treating the hair with said agents activates the keratin synthesis of hair keratin th...
|
|
WO/2008/028775A1 |
The invention relates to cosmetic agents, in particular hair treatment agents, containing at least one specific betaine and at least one bioquinone. Treating the hair with said agents activates hair growth, strengthens the internal hair ...
|
|
WO/2008/028772A1 |
The present invention relates to the cosmetic use of one or more bioquinones for combating age-related changes in the hair follicles, for the promotion of keratin synthesis in the hair, and for positively influencing the structure of the...
|
|
WO/2008/028895A1 |
Programmed cell death (Apoptosis) of hair follicular cells is promoted or initiated prematurely by stress factors, particularly as part of oxidative hair treatments. The use of quaternized beta-hydroxy butyric acid derivatives protects t...
|
|
WO/2008/028778A2 |
The invention relates to the cosmetic use of pantolactone for increasing the cell proliferation in hair follicle centres, reducing apoptosis of hair keratinocytes and extending the anagenic phase. The invention also relates to a cosmetic...
|
|
WO/2008/028774A1 |
The invention relates to cosmetic agents, in particular hair treatment agents, containing at least one derivative of 2-furanone and at least one bioquinone. Treating the hair with said agents activates hair growth.
|
|
WO/2008/028773A1 |
The invention relates to cosmetic agents, in particular hair treatment agents, containing at least one purine and/or purine derivative and at least one bioquinone. Treating the hair with said agents activates hair growth, strengthens the...
|
|
WO/2008/026776A1 |
It is intended to provide a transdermal composition comprising a polymer micelle encapsulating a transdermally absorbed active ingredient with a block copolymer having a hydrophobic region and a hydrophilic region as a whole; a transderm...
|
|
WO/2008/026349A1 |
A therapeutic agent for telogen effluvium, comprising leptin or a partial peptide thereof as an active ingredient. The therapeutic agent is useful for changing the telogen phase in the hair growth cycle to the anagen phase to treat telog...
|
|
WO/2008/027541A2 |
Hair care compositions, methods, and articles of commerce that can increase the appearance of thicker and fuller hair. Such compositions can be applied to any areas where a thicker and fuller hair appearance is desired, such as the scalp...
|
|
WO/2008/023960A1 |
Disclosed are uses of rare earth element selected from the group consisting of cerium (Ce), praseodymium (Pr), promethium (Pm), europium (Eu), terbium (Tb), dysprosium (Dy), holmium (Ho), erbium (Er), thulium (Tm), ytterbium (Yb), scandi...
|
|
WO/2008/020490A1 |
Disclosed is a substance having an ability of inhibiting a testosteron-5α-reductase activity, an ability of inhibiting or reducing the proliferation of a cancer cell, an ability of inhibiting a cyclooxygenase, an ability of inhibiting a...
|
|
WO/2008/018448A1 |
At least one kind of a biosurfactant, in particular, a mannosyl alditol lipid (MEL, MML or the like) or a triacyl derivative of the same is used as an active ingredient. Thus, it becomes possible to provide an activator or an anti-aging ...
|
|
WO/2008/016230A1 |
A hair growth stimulant is provided. The hair growth stimulant uses carbonized chestnut burrs that exhibit excellent stimulatory effects on hair restoration and hair growth effects without causing side effect and toxicity. The hair growt...
|
|
WO/2008/004165A2 |
The present invention relates to a cosmetic use of at least one C-glycoside derivative in a composition comprising a physiologically acceptable medium, as a cosmetic agent for promoting the desquamation of the skin and/or the scalp and/o...
|
|
WO/2007/142349A1 |
Disclosed is a hair growth agent having a novel mechanism of action. Also disclosed is a hair growth composition comprising the hair growth agent. More specifically, disclosed is a novel hair growth composition comprising at least one me...
|
|
WO/2007/136125A1 |
Disclosed are: a composition for inhibiting the transcription of an extracellular matrix gene, comprising a compound having a heterocyclic ring represented by the formula (I) and an inert carrier; and others.
|
|
WO/2007/132948A1 |
Disclosed are: a composition for inhibiting the extracellular matrix gene transcription, which comprises a cinnamoyl compound represented by the formula (I) and an inert carrier; and others.
|
|
WO/2007/132945A1 |
Disclosed are: a composition for inhibiting the extracellular matrix gene transcription, which comprises a cinnamoyl compound represented by the formula (I) and an inert carrier; and others.
|
|
WO/2007/128983A1 |
A personal care article including a substrate having impregnated therein, applied thereon or arranged to substantially encase, a cosmetic composition which includes a hair modification active, wherein the pH of the composition is substan...
|
|
WO/2007/115840A1 |
A cosmetic composition with the following essential active principles: a) antiandrogens in an amount equivalent to those supplied by between 2.00 and 4.00 mg of synthetic cyproterone acetate; b) oestrogens in an amount equivalent to thos...
|
|
WO/2007/116023A1 |
The application relates to novel heterocyclic compounds of the general formula (I) and salts, preferably pharmaceutically acceptable salts, thereof, in which R, R1, R2, R3, Q, m and n have the meanings explained in detail in the descript...
|
|
WO/2007/116021A1 |
The invention relates to the use of at least one galactose C-glycoside derivative of general formula (I) as protective agent and/or as activity or proliferation promoter for T-lymphocyte cells of the gamma-delta type (γδT cells) in a c...
|
|
WO/2007/116017A1 |
The invention relates to the use of compounds of general formula (I), D- and L-fucose derivatives as protective agent and/or as activity or proliferation promoter for T-lymphocyte cells of the gamma-delta type (T cells) in a composition ...
|
|
WO/2007/113851A2 |
Novel compositions for hair loss prevention and/or hair growth promotion comprising at least active agent preferably derived from natural source such as from the plant Vernonia sp., either alone or in combination with other active agent(...
|
|
WO/2007/113892A2 |
The invention relates to the use of a Sambucus Nigra L. decoction obtainable by boiling two-years old branches for a time period comprised between 15 minutes and 10 hours, then cooling and harvesting the decoction, for the preparation of...
|
|
WO/2007/108632A1 |
Disclosed herein is a natural oriental medicinal composition for the promotion of hair growth. The oriental medicinal composition comprises a black bean extract, a tangerine extract, a potato extract, a pine needle extract and a quartzit...
|
|
WO/2007/101354A1 |
Methods of treating, reducing and inhibiting the appearance of ageing in the skin are provided. Also provided are uses and methods of maintaining a youthful appearance, reducing an appearance of ageing, inhibiting an appearance of ageing...
|
|
WO/2007/102451A1 |
The invention provides a hair grower having a hair-glowing effect and useful application forms of the hair grower. The invention relates to a hair grower containing as the active ingredient a lithospermic acid derivative represented by t...
|
|
WO/2007/085846A1 |
Use of a peptide comprising a Bowman-Birk molecule in which the chymotrypsin inhibitory sequence and/or trypsin inhibitory sequence is replaced with a vascular endothelial growth factor binding sequence to retard hair growth.
|
|
WO/2007/086327A1 |
An object is to provide a dermal papilla cell growth promoter, which can be achieved by providing a dermal papilla cell growth promoter comprising as an active ingredient one or more members selected from substances having a lipolysis in...
|
|
WO/2007/074602A1 |
By preparing a cosmetic for hair containing one or more hair growth active ingredients selected from (A) a cell activator, (B) a blood circulation improving agent, (C) an antiinflammatory agent, (D) a bactericide and (E) a local stimulan...
|
|
WO/2007/068339A1 |
The present invention relates to cosmetic compositions for treating the skin and/or the scalp and/or the hair and/or for oral and dental hygiene, in particular deodorant or antitranspirant compositions, which contain certain esters of si...
|
|
WO/2007/069804A1 |
The present invention relates to a hair growth stimulant, and more particularly to a hair growth stimulant having excellent hair growth stimulation and hair growth effects without any side effects, which contains a carbonized pine cone. ...
|
|
WO/2007/066832A1 |
[PROBLEMS] To provide emulsified particles which are constituted of an antioxidant having a surface tension lowering effect or a derivative thereof, a liquid matrix, a fat-soluble substance, and a solvent and which are excellent in stabi...
|
|
WO/2007/046636A1 |
The present invention relates to a composition comprising an extract of complex herb consisting of Rehmania glutinosa Libschitz var purpurea Makino, polygonum multiflorum THUNB. and Polygonatum sibiricum Redt and it showed potent promoti...
|
|
WO/2007/042824A1 |
A microemulsion comprising an oil phase, an aqueous phase, a surfactant, and a hair modification active. The microemulsion is suitable for being impregnated therein or deposited thereon a substrate.
|
|
WO/2007/034927A1 |
It is intended to find a novel medicinal application of sphingomyelin and to provide a preventive agent or a therapeutic agent for various diseases and a food and drink and feed containing the agent. A medicine which contains sphingomyel...
|
|
WO/2007/031950A2 |
A composition for reducing hair growth includes α-difluoromethylornithine, an antiperspirant salt or deodorant active ingredient, and a vehicle.
|
|
WO/2007/029187A2 |
The present invention relates to cosmetic use, by topic application on the skin of at least one protoberberine, with exception of berberine, or a vegetable extract containing it, as an active substance reducing activity of the pilosebace...
|
|
WO/2007/023841A1 |
A minoxidil preparation has an excellent hair growth effect, however, further more excellent preparation has been demanded. In view of this, as a result of studying in various ways in order to further improve the excellent hair growth ef...
|
